Comvita Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CVNZF research report →
Price Chart
About the company
Comvita Limited, in conjunction with its affiliated entities, operates on an international scale, concentrating on the creation and distribution of a diverse range of natural wellness products. Its extensive offerings encompass renowned items like Manuka honey, propolis, and olive leaf extract. The company also provides specialized honey varieties, including Medihoney and gourmet options, along with elixirs, lozenges, and dedicated lines for oral hygiene and children's health.
- CEO
- Karl Gradon
- IPO
- 2009
- Employees
- 400
- HQ
- Te Puke, BP, NZ
Get TickerSpark's AI analysis on CVNZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $30.05M
- P/E
- -0.60
- Fwd P/E
- 5.17
- PEG
- 0.03
- P/S
- 0.27
- P/B
- 0.96
- EV/EBITDA
- -40.48
- Div Yield
- 0.00%
- Gross Margin
- 42.29%
- Op Margin
- -12.79%
- Net Margin
- -44.47%
- ROE
- -165.47%
- ROIC
- -19.65%
Latest fiscal year · YoY change
- Revenue
- $192.43M-5.8%
- Gross Profit
- $82.70M-26.4%
- Op Income
- $-28,986,000
- Net Income
- $-104,759,000-35.4%
- EPS
- $-1.49-35.5%
- OCF Growth
- +540.1%
- FCF Growth
- +806.9%
- 52W High
- $1.56
- 52W Low
- $0.32
- 50D MA
- $0.44
- 200D MA
- $0.45
- Beta
- 0.27
- RSI (14)
- 58
- Avg Volume
- 40
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Comvita said it is back on track in H1 FY26, with improved profitability, cash flow, and inventory reduction, while keeping full-year guidance unchanged amid an ongoing recapitalization process.· February 22, 2026
- H1 progress was broad-based: management said revenue growth, profitability, cash flow, net debt and inventory reduction were all on or ahead of target.
- Normalized FY26 EBIT guidance was reaffirmed at $14.3 million, or $13.5 million pre-IFRS 16.
- Inventory fell to $68.3 million at 31 December 2025 from $145.8 million at December 2023, and net debt fell to $48.7 million from $62.4 million at FY25 year-end.
- U.S. club retail was the main growth engine, offsetting softer performance in ANZ and some digital channels.
- The board said recapitalization remains the top priority, with interest from existing, prospective, and an offshore strategic investor at $0.80 per share.
Comvita did not give a revenue or EPS figure in the prepared remarks, but it reported that H1 FY26 delivered improvements across key financial metrics. Mandy Tomkins-Dancey said H1 cost savings were achieved despite $1.4 million of transaction costs, inventory fell to $68.3 million from $145.8 million at December 2023, cash conversion improved from 484 days to 239 days, and net debt was $48.7 million versus $62.4 million at FY25 year-end and $81.6 million a year earlier. The company reaffirmed full-year FY26 normalized EBIT guidance of $14.3 million, or $13.5 million pre-IFRS 16, unchanged from the ASM. Gross margin guidance was said to remain in line with prior disclosures, with expectations of around 51% in the medium term.
Karl Gradon said the company has made significant progress over the past 6 months and is focused on disciplined execution, diversification, and restoring sustainable growth. He emphasized that Comvita is strengthening its premium positioning, expanding innovation beyond core honey products, and improving leadership, cost structure, and risk management. He was upbeat on North America, where club retail is helping the brand reach the right consumer and where he still sees room for growth because household penetration remains low.
Mandy Tomkins-Dancey focused on the financial reset: stronger U.S. club retail performance drove volume, sales, profitability and overhead recovery, while cost-out actions from FY25 continued to flow through. She cited $1.4 million of transaction costs, inventory down to $68.3 million from $145.8 million, cash conversion improving from 484 days to 239 days, and net debt at $48.7 million. She said further working capital improvement should not be expected to the same degree in H2, and reiterated full-year normalized EBIT guidance of $14.3 million, with gross margins expected to return to around 51% in the medium term.
Analysts focused on the dividend outlook, dilution from the recapitalization, FX risk, the sustainability of U.S. club retail growth, gross margin recovery, and whether the strong inventory reduction was driven by genuine operating cash flow or inventory sell-through. Management said a dividend is a priority eventually, but not for the near term, and said it could not yet quantify dilution because the capital raise terms are still being finalized. On margins, Mandy said gross margin is expected to return to around 51% in the medium term, while Karl said U.S. growth still has room to run but H1 is likely to be softer seasonally than H2. On FX, Karl said hedging is in place and he does not expect surprises this financial year.
The call showed real operational momentum: Comvita said it has returned to profitability, reduced debt and inventory, and improved cash conversion while keeping full-year guidance intact. Management also sounded constructive on North America, product innovation, and the ability to grow profitably through better channel mix and brand differentiation.
China remains challenging, ANZ is still weak, and management acknowledged intensifying competition and FX risk. The recapitalization is still unresolved, dilution is unknown, and the board said a dividend is not in the near-term plan, which highlights that the balance sheet repair is still a work in progress.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 75.7%
- Shares Outstanding
- 72.22M
- Float Shares
- 54.70M
Our CVNZF coverage
Recent articles, reports, and earnings notes.
No research on CVNZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CVNZF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.